In our study, Ualcan online database analysis showed increased promoter methylation of MAN1A1 in prostate cancer patients compared to healthy controls and in metastatic prostate cancer patients compared to non-metastatic prostate cancer patients. This evidence concerns the gene MAN1A1 and metastatic prostate carcinoma.